Extensive Preclinical Research Services

Biomere is a preclinical contract research organization (CRO) that offers an extensive portfolio of preclinical research services from in vitro analyses, early discovery and proof-of-concept to discovery toxicology.

Nonclinical capabilities include: pharmacokinetics, lead compound screening, proof of concept, efficacy assessment, pharmacology, mechanism of action, and early lead optimization. Biomere also provides supportive colony maintenance, backup colony support and on site room use agreements.

Biomere provides multiple levels of containment and has been pathogen free since 1989.